🔥🐔 BizChicken 🐔🔥
Companies Similar to Cencora
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Citius Pharmaceuticals, Inc.
Mino-Lok, Mino-Wrap, Halo-Lido, Nove Cite, I/ONTAK
Citius Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of critical care products, including anti-infective products, adjunct cancer care, prescription products, and stem cell therapy.
About | Leadership | Directors | About | About | About | About | Contact | Contact | About | About
Symbol: CTXR
Recent Price: $3.91
Industry: Biotechnology
CEO: Mr. Leonard L. Mazur
Sector: Healthcare
Employees: 22
Address: 11 Commerce Drive, Cranford, NJ 07016
Phone: 908 967 6677
Leadership
- Leonard Mazur, Co-Founder, CEO & Chairman of the Board of Director
- Myron Holubiak, Co-Founder, Executive Vice Chairman
- Jaime Bartushak, Chief Financial Officer & Chief Business Officer
- Myron S. Czuczman, MD, Chief Medical Officer and EVP
- Gary F. Talarico, EVP, Operations
- Jay Wadekar, SVP, Business Strategy
- Kelly Creighton, PhD, EVP, Chemistry, Manufacturing and Controls
- Catherine Kessler, MS, EVP, Regulatory Affairs
- Nikolas Burlew, EVP, Quality Assurance
- Alan Lader, PhD, SVP, Head of Clinical Operations and Quality Assurance
- Ilanit Allen, VP, Investor Relations
- John Westman, VP, Project Management
- Paul Sowyrda, VP, Business Development & Market Intelligence
- Suren Dutia, Director
- Eugene Holuka, MD, Director
- Carol Webb, Director
- Dennis M. McGrath, Director
- Robert Smith, Director
Last updated: 2024-12-31
Certara, Inc.
Biosimulation Software and Services
Certara, Inc. provides biosimulation software and technology-enabled services for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access, helping to guide new drugs through the regulatory process to patients.
About | About | Locations | Leadership | About | News | About | Contact | Our Story | Careers | Jobs | Jobs | Culture | Benefits | Culture | Benefits | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About
Symbol: CERT
Recent Price: $10.54
Industry: Medical - Healthcare Information Services
CEO: Dr. William F. Feehery Ph.D.
Sector: Healthcare
Employees: 1338
Address: 100 Overlook Center, Princeton, NJ 08540
Phone: 609 716 7900
Leadership
- William F. Feehery, Chief Executive Officer
- John E. Gallagher III, Chief Financial Officer
- Max Kanevsky, Chief Technology Officer
- Leif E. Pedersen, President, Chief Commercial Officer
- Rona Anhalt, Chief Human Resources Officer
- Ron DiSantis, SVP of Corporate Development
- Robert Aspbury, President, Certara Scientific Software
- Daniel Corcoran, Chief Counsel
- Sheila Rocchio, Chief Marketing Officer
- Patrick F. Smith, President, Certara Drug Development Solutions
- James E. Cashman III, Chairman of the Board
- Eran Broshy,
- Cynthia Collins,
- Rosemary Crane,
- Nancy Killefer,
- Stephen McLean,
- Matthew Walsh,
- David Spaight,
- John Reynders,
Last updated: 2024-12-31
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Regeneron Pharmaceuticals, Inc.
EYLEA, Dupixent, Libtayo, Praluent, REGEN-COV, Kevzara, Inmazeb
Regeneron Pharmaceuticals, Inc. discovers, develops, manufactures, and commercializes medicines for treating various diseases worldwide, including treatments like EYLEA, Dupixent, Libtayo, and more.
About | Leadership | About | History | About | About | Contact | Careers | Careers | Jobs | Jobs | Jobs | Careers | Culture | DEI | Careers | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Leadership | Careers | Careers | Careers | Locations | Locations | Locations | Locations | Events | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Site Map | Careers | About | About | About | About | Jobs | About | Leadership | Careers | Careers | About | Jobs | Jobs | Careers
Symbol: REGN
Recent Price: $702.59
Industry: Biotechnology
CEO: Dr. Leonard S. Schleifer M.D., Ph.D.
Sector: Healthcare
Employees: 14165
Address: 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707
Phone: 914 847 7000
Leadership
- Leonard S. Schleifer, MD, PhD, Board co-Chair, President and Chief Executive Officer
- George D. Yancopoulos, MD, PhD, Board co-Chair, President and Chief Scientific Officer
- Zoran Berkovic, Senior Vice President, Financial Planning and Analysis
- Maya Bermingham, Senior Vice President, Public Policy and Government Affairs
- Leonard Brooks, Senior Vice President, Treasurer
- John Calabro, Senior Vice President, Internal Audit
- Christina Chan, Senior Vice President, Corporate Affairs
- Larry Coury, PhD, Senior Vice President, Associate General Counsel
- Ryan Crowe, Senior Vice President, Investor Relations & Strategic Analysis
- Matthew Everett, Senior Vice President, Global Procurement
- Chris Fenimore, Senior Vice President, Finance and Chief Financial Officer
- Rick Hall, Senior Vice President, Human Resources
- Justin Holko, Senior Vice President, Global Oncology/Hematology Commercial Business Unit
- Nouhad Husseini, Senior Vice President, Business Development
- Joseph J. LaRosa, Executive Vice President, General Counsel and Secretary
- Melissa Lozner, Senior Vice President, Chief Compliance Officer
- Marion McCourt, Executive Vice President, Commercial
- Bob McCowan, Senior Vice President, IT and Chief Information Officer
- Gonzalo Merino, PhD, Senior Vice President, Chief Intellectual Property Counsel and Associate General Counsel
- Richard O’Neal, Senior Vice President, Market Access
- Sally A. Paull, Executive Vice President, Human Resources
- Smita Pillai, Senior Vice President, Culture and DEI and Chief DEI Officer
- George Poth, Senior Vice President, Real Estate & Facilities Management
- Alessandra Ravetti, Senior Vice President, Associate General Counsel
- Kerry Reinertsen, PhD, Senior Vice President, Strategic Alliances
- David Snow, Senior Vice President, Global Head, Dupixent Franchise
- Mark Volpe, Senior Vice President, Tax
- Bola Akinlade, MD, FACP, Senior Vice President, Clinical Development, Immunology and Inflammation
- Hanne Bak, PhD, Senior Vice President, Preclinical Manufacturing and Process Development
- Aris Baras, MD, Senior Vice President, Regeneron Genetics Center®
- Ned Braunstein, MD, Executive Vice President, Regulatory Affairs and Global Patient Safety
- Gang Chen, PhD, Senior Vice President, Protein Expression Sciences
- Thomas DiCioccio, PhD, Senior Vice President, Pharmacometrics
- Benjamin Drosman, Senior Vice President, Global Development Quality & Regulatory Compliance
- Gregory Geba, MD, PhD, Senior Vice President, Global Development Scientific Council
- Philip Gregory, DPhil, Senior Vice President, Regeneron Cell Medicines
- Gary Herman, MD, Senior Vice President, Early Clinical Development and Experimental Sciences
- Boaz Hirshberg, MD, Senior Vice President, Clinical Sciences General Medicine
- Diana Hughes, MBBS, Senior Vice President, Global Patient Safety
- Bari Kowal, Senior Vice President, Development Operations and Portfolio Management
- Christos Kyratsous, PhD, Senior Vice President, Research
- Johnathan Lancaster, MD, PhD, Senior Vice President, Global Medical Affairs
- John Lin, MD, PhD, Senior Vice President, Immuno-Oncology and Head of Bispecifics
- Israel Lowy, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Oncology
- Lynn Macdonald, PhD, Senior Vice President, Research
- Lori Morton, PhD, Senior Vice President, Research
- Andrew Murphy, PhD, Executive Vice President, Research
- Muriel O'Byrne, PhD, Senior Vice President, International Regulatory Affairs & Head, European Business Office
- William Olson, PhD, Senior Vice President, Therapeutic Proteins
- Mohammed Shameem, PhD, Senior Vice President, Formulations Development
- L. Andres Sirulnik, MD, PhD, Senior Vice President, Translational and Clinical Sciences, Hematology
- Randy Soltys, PhD, Senior Vice President, Drug Safety and Pharmacometrics
- Neil Stahl, PhD, Executive Vice President, Research and Development
- Robert Vitti, MD, Senior Vice President, Clinical Trial Excellence Strategy
- Brian Zambrowicz, PhD, Executive Vice President, Functional Genomics and Chief VelociGene® Operations
- Rajesh Ahuja, Senior Vice President, Fill/Finish and External Manufacturing
- Frederick Austin, Senior Vice President, Quality Control, Raheen
- Christine Childrose, Senior Vice President, Human Resources and HR Operations
- David Crenshaw, Senior Vice President, Associate General Counsel
- Tikiri Dissanayake, Senior Vice President, IOPS Technical Operations
- Patrice Gilooly, Senior Vice President, Quality Assurance and Operations
- Jennifer McNay, PhD, Senior Vice President, CMC Regulatory Sciences and Industrial Affairs
- Niall O’Leary, Senior Vice President and Site Head, IOPS Raheen
- Scott Oberman, Senior Vice President, Supply Chain Operations
- David Simon, Senior Vice President, IOPS Finance and Business Operations
- Daniel Van Plew, Executive Vice President and General Manager, Industrial Operations and Product Supply
- Benjamin Yocum, Senior Vice President, Manufacturing Operations
- James Wolfe, Senior Vice President, Process Sciences and Drug Product Engineering
- Bonnie L. Bassler, PhD, Director
- Michael S. Brown, MD, Director
- N. Anthony Coles, MD, Chair of the Board
- Joseph L. Goldstein, MD, Director
- Kathryn Guarini, PhD, Director
- Christine A. Poon, Lead Independent Director
- Arthur F. Ryan, Director
- Huda Y. Zoghbi, MD, Director
- Samantha Dickon, Director, Development Program Management
- Gervasio Batista, Sr. Scientist, Neuroscience
- James K. Gibson, Senior Regional Director, Immunology/Pulmonary
- Beth Brause, Director, Field Reimbursement Management
- Eric Prendergast, Director, Pricing Strategy
- Ashley Neff, Manager, Digital Communications
- Shari Loock, Associate Director, Sourcing
- Jennifer Davidson Hamilton, VP and Head of Precision Medicine
- Yi Zhang, Director, Health Economics & Outcomes Research
- Wilson Caldwell III, Director, GCO Vendor & Relationship Management
- David Stein, Director, Medical Operations
- Regeneron, Corporate
- Grant Anicete, Biotech Production Specialist I / IOPS Rensselaer
- Mary McKenna, Lead Quality Control Analyst / IOPS Raheen
- Ashley Lebby, Lead Senior Biotech Production Specialist / IOPS Rensselaer
- Varenka Rodriguez Diblasi, Principal Scientist, Bioinformatics
- Jessie Brown, Manager, Integrative Translational Genetics
- Gisu Eom, Lead Cloud DevOps Engineer
- Carmen Kenworthy, Scientist, Velocigene
- Ralph Hazlewood, Sr. Manager, Research Program Management
- Brandy Bennett, Sr. Director, R&D Strategy & Operations
Last updated: 2024-12-31
Concentra Group Holdings Parent, Inc.
Concentra Telemed
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States, offering urgent care, clinical testing, preventative care, and wellness programs. The company also provides telemedicine and compliance administration services.
About | About | Leadership | About | About | About | About | About | About | About | Contact | Careers | About | About | About | Jobs | Jobs | Careers | Careers | About | About | About | Locations | Jobs | Jobs | Careers | Jobs | Jobs | About | Careers | Careers | Careers | Leadership | Jobs | Careers | Jobs | Jobs | Careers | Careers | Jobs | Careers | Careers | About | Jobs | About | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Leadership | Leadership | Jobs | Careers | Careers | Careers | Careers | Jobs | Jobs | Jobs | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Benefits | Benefits | Careers | Jobs | Careers | Jobs | About | Jobs | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Jobs | Careers | Leadership | Careers | Jobs | Careers | Jobs | Jobs | Benefits | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | Careers | Careers | About | Careers
Symbol: CON
Recent Price: $20.11
Industry: Medical - Equipment & Services
CEO: Mr. William Keith Newton
Sector: Healthcare
Employees: 11000
Address: 4714 Gettysburg Road, Mechanicsburg, PA 17055
Phone: (717) 972-1100
Last updated: 2024-12-31
Zentalis Pharmaceuticals, Inc.
ZN-c3, ZN-c5
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics for treating various cancers. Its leading product candidates include ZN-c3 and ZN-c5, which are in various phases of clinical trials targeting specific cancer types.
About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About
Symbol: ZNTL
Recent Price: $2.92
Industry: Biotechnology
CEO: Dr. Kimberly Lynn Blackwell M.D.
Sector: Healthcare
Employees: 124
Address: 1359 Broadway, New York, NY 10018
Phone: 212 433 3791
Last updated: 2024-12-31
Pfizer Inc.
biopharmaceutical products
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide, offering medicines and vaccines across various therapeutic areas.
About | About | About | About | About | About | About | About | About | About | DEI | ESG | About | Safety | About | ESG | About | About | About | About | About | About | About | About | About | About | History | About | About | About | About | About | About | News | About | Directors | Contact | Careers | Careers | Careers | Careers | Careers | Careers | DEI | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About
Symbol: PFE
Recent Price: $26.42
Industry: Drug Manufacturers - General
CEO: Dr. Albert Bourla D.V.M., Ph.D.
Sector: Healthcare
Employees: 88000
Address: 235 East 42nd Street, New York, NY 10017
Phone: 212 733 2323
Last updated: 2024-12-31
West Pharmaceutical Services, Inc.
containment and delivery systems for injectable drugs and healthcare products
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products globally. They operate in two segments: Proprietary Products and Contract-Manufactured Products, offering solutions like stoppers, seals, syringe components, and advanced drug delivery technologies.
About | About | About | Culture | Contact | Careers | Careers | Careers | About | About | About | About
Symbol: WST
Recent Price: $328.82
Industry: Medical - Instruments & Supplies
CEO: Mr. Eric M. Green
Sector: Healthcare
Employees: 10600
Address: 530 Herman O. West Drive, Exton, PA 19341-0645
Phone: 610 594 2900
Last updated: 2024-12-31
CalciMedica, Inc.
Auxora
Calci Medica, Inc. is a clinical-stage biotechnology company focusing on therapies for life-threatening inflammatory diseases, with a proprietary CRAC channel inhibitor technology. Its lead product candidate, Auxora, aims to treat conditions such as acute pancreatitis and acute kidney injury.
Symbol: CALC
Recent Price: $3.29
Industry: Biotechnology
CEO: Dr. A. Rachel Leheny Ph.D.
Sector: Healthcare
Employees: 13
Address: 505 Coast Boulevard South, La Jolla, CA 92037
Phone: 858-952-5500
Last updated: 2024-12-31
Coherus BioSciences, Inc.
UDENYCA
Coherus Bio Sciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. It markets UDENYCA and develops various biosimilar and immuno-oncology products.
Symbol: CHRS
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Dennis M. Lanfear
Sector: Healthcare
Employees: 306
Address: 333 Twin Dolphin Drive, Redwood City, CA 94065
Phone: 650 649 3530
Last updated: 2024-12-31
Kiora Pharmaceuticals, Inc.
KIO-301
Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.
Symbol: KPRX
Recent Price: $3.30
Industry: Biotechnology
CEO: Dr. Brian M. Strem Ph.D.
Sector: Healthcare
Employees: 12
Address: 1371 East 2100 South, Salt Lake City, UT 84105
Phone: 781 788 8869
Last updated: 2024-12-31
MIRA Pharmaceuticals, Inc.
MIRA1a
MIRA Pharmaceuticals, Inc. is a clinical development stage biopharmaceutical company focusing on the development and commercialization of a new molecular synthetic THC analog for treating anxiety and cognitive decline associated with early-stage dementia.
Symbol: MIRA
Recent Price: $1.14
Industry: Drug Manufacturers - General
CEO: Mr. Erez Aminov
Sector: Healthcare
Employees: 2
Address: 855 North Wolfe Street, Baltimore, MD 21205
Phone: 737-289-0835
Leadership
- Erez Aminov, Chairman of the Board and Chief Executive Officer
- Itzchak Angel, PhD, Chief Scientific Advisor
- Michelle Yanez, MBA, Chief Financial Officer, Secretary, and Treasurer
- Matthew Del Giudice, MD, Director
- Michael Jerman, Director
- Ned Macpherson, Director
- Denil N. Shekhat, MD, Director
Last updated: 2024-12-31
scPharmaceuticals Inc.
FUROSCIX
sc Pharmaceuticals Inc. is a pharmaceutical company focused on developing and commercializing pharmaceutical products, with a lead product candidate, FUROSCIX, aimed at treating congestion in heart failure patients using an on-body infusor.
About | Leadership | Contact | Contact | Careers | About | About | About | About | Careers | Careers | Careers | Careers | About | About | About
Symbol: SCPH
Recent Price: $3.50
Industry: Biotechnology
CEO: Mr. John H. Tucker
Sector: Healthcare
Employees: 135
Address: 2400 District Avenue, Burlington, MA 01803
Phone: 617 517 0730
Leadership
- John H. Tucker, President and Chief Executive Officer
- Rachael Nokes, Chief Financial Officer
- Mike Hassman, Senior Vice President, Technical Operations
- John Mohr, Pharm.D., FIDP, Senior Vice President, Clinical Development and Medical Affairs
- William T. Abraham, MD,
- Mette Kirstine Agger, Co-Founder & CEO, 7TM Pharma A/S
- Minnie V. Baylor-Henry, President, B-Henry & Associates
- Sara Bonstein, CFO, Insmed Incorporated
- Frederick Hudson, Former Partner in Charge of KPMG’s Largest Healthcare Industry Audit Practice Located in the Mid-Atlantic Region
- Jack A. Khattar, Founder, President & Chief Executive Officer, Supernus Pharmaceuticals
- Leonard D. Schaeffer, Founding Chairman & CEO, Wellpoint
- Klaus Veitinger, MD, PhD, Venture Partner, Orbimed
- Dan Bensimhon, MD, Medical Director Advanced Heart Failure & Mechanical Circulatory Support Program, Cone Health, Greensboro, NC
- G. Michael Felker, MD, Chief, Heart Failure Service, Division of Cardiology, Duke University School of Medicine
- Marv Konstam, MD, Professor of Medicine, Tufts University School of Medicine, Chief Physician Executive of the Cardiovascular Center at Tufts Medical Center
- W. Frank Peacock, MD, FACEP, FACC, FESC, Professor, Vice Chair of Research, Department of Emergency Medicine, Baylor College of Medicine, Ben Taub General Hospital
- Stuart Russell, MD, Regional Director of Heart Failure Program, Duke University School of Medicine
- James E. Udelson, MD, Chief, Division of Cardiology, Tufts Medical Center, Professor of Medicine and Radiology Tufts University School of Medicine
- William Weintraub, MD, Director of Outcomes Research, MedStar Heart and Vascular Institute
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Verrica Pharmaceuticals Inc.
VP-102, VP-103
Verrica Pharmaceuticals Inc. develops and commercializes treatments for skin diseases in the United States, including products for molluscum contagiosum and warts. The company collaborates with Torii Pharmaceutical Co., Ltd., and Lytix Biopharma AS for further development and commercialization efforts.
Symbol: VRCA
Recent Price: $0.70
Industry: Biotechnology
CEO: Mr. Ted White
Sector: Healthcare
Employees: 100
Address: 44 West Gay Street, West Chester, PA 19380
Phone: 484 453 3300
Last updated: 2024-12-31
X4 Pharmaceuticals, Inc.
mavorixafor
X4 Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company dedicated to the development and commercialization of novel therapeutics for rare diseases, with its lead product mavorixafor in advanced clinical trials.
Symbol: XFOR
Recent Price: $0.81
Industry: Biotechnology
CEO: Dr. Paula Ragan Ph.D.
Sector: Healthcare
Employees: 127
Address: 61 North Beacon Street, Boston, MA 02134
Phone: 857 529 8300
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Cencora
pharmaceutical products
Cencora, Inc. sources and distributes pharmaceutical products, offering a range of services including pharmacy management, supply management software, packaging solutions, and clinical trial support to various healthcare providers and manufacturers.
About | About | About | History | Leadership | Contact | Careers | Careers | Culture | Careers | DEI | Careers | Careers | Careers | DEI | Jobs | Jobs | Jobs | Jobs | Jobs | Management | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Management | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Locations | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: COR
Recent Price: $224.71
Industry: Medical - Distribution
CEO: Dr. Robert P. Mauch Ph.D., PharmD
Sector: Healthcare
Employees: 46000
Address: 1 West First Avenue, Conshohocken, PA 19428
Phone: 610 727 7000
Last updated: 2024-12-31
Cosmos Health Inc.
pharmaceuticals, nutraceuticals, medical devices
Cosmos Health Inc. is a vertically integrated pharmaceutical company offering branded and generic pharmaceuticals, medical devices, and more, serving wholesale distributors and retail pharmacies. Headquartered in Chicago, it has distribution centers in Greece and the UK.
Symbol: COSM
Recent Price: $0.67
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Grigorios Siokas
Sector: Healthcare
Employees: 123
Address: 141 West Jackson Boulevard, Chicago, IL 60604
Phone: 312 536 3102
Last updated: 2024-12-31